Integrated Data Mining and Animal Experiments to Investigate the Efficacy and Potential Pharmacological Mechanism of a Traditional Tibetan Functional Food . in Hyperuricemia

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Dec 23

PMID 39713714

Authors

Wenbin Liu

Mingchao Zhang

Jingli Tan

Hao Liu

Lijun Wang

Jingyang Liao

Dan Huang

Wang Jie

Xiaobao Jin

Affiliations

Soon will be listed here.

Abstract

Background: Hyperuricemia (HUA), a common metabolic disorder associated with gout, renal dysfunction, and systemic inflammation, necessitates safer and more comprehensive therapeutic approaches. Traditional Tibetan medicine has a rich history of treating HUA. This study aimed to identify novel anti-hyperuricemic herb derived from traditional Tibetan medicine.

Methods: Traditional Tibetan medicine prescriptions for HUA were analyzed using data mining techniques, identifying as a high-frequency herb. Its phytochemical composition was characterized by UPLC-QE-Orbitrap-MS. Hyperuricemic rat models were treated with to assess its effects on serum uric acid (UA) levels, renal inflammation, intestinal barrier integrity, and gut microbiota composition. Molecular and histological analyses evaluated its impact on key biomarkers.

Results: Through data mining, we identified as a promising candidate for HUA treatment. demonstrated dose-dependent inhibition of xanthine oxidase (XOD) in vitro and significantly reduced serum UA levels and XOD activity in vivo. It restored gut barrier function by upregulating tight junction proteins (ZO-1, Occludin, Claudin-1) and reduced pro-inflammatory cytokines (IL-6, TNF-α). improved renal function, reducing serum creatinine (Cre) and blood urea nitrogen (BUN) levels. Gut microbiota analysis revealed a favorable shift in microbial composition, with reductions in harmful bacteria (eg, spp.) and increases in beneficial bacteria (eg, ). These effects aligned with the modulation of the gut-kidney axis.

Conclusion: This study highlights the multi-target therapeutic potential of in HUA management. By regulating the gut-kidney axis, alleviates systemic inflammation, enhances intestinal and renal health, and addresses critical aspects of HUA pathology. These findings underscore the value of integrating traditional medicine with modern scientific methodologies to develop innovative treatments.

References

Petreski T, Ekart R, Hojs R, Bevc S . Hyperuricemia, the heart, and the kidneys - to treat or not to treat?. Ren Fail. 2020; 42(1):978-986. PMC: 7534372. DOI: 10.1080/0886022X.2020.1822185. View

Pan B, Zhang H, Hong Y, Ma M, Wan X, Cao C . Indoleamine-2,3-Dioxygenase Activates Wnt/β-Catenin Inducing Kidney Fibrosis after Acute Kidney Injury. Gerontology. 2021; 67(5):611-619. DOI: 10.1159/000515041. View

Salvi P, Cowles R . Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease. Cells. 2021; 10(7). PMC: 8304699. DOI: 10.3390/cells10071775. View

Yang B, Xin M, Liang S, Huang Y, Li J, Wang C . Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway. J Agric Food Chem. 2022; 71(3):1434-1446. DOI: 10.1021/acs.jafc.2c01513. View

Chen Y, Pei C, Chen Y, Xiao X, Zhang X, Cai K . Kidney tea ameliorates hyperuricemia in mice via altering gut microbiota and restoring metabolic profile. Chem Biol Interact. 2023; 376:110449. DOI: 10.1016/j.cbi.2023.110449. View

He S, Xiong Q, Tian C, Li L, Zhao J, Lin X . Inulin-type prebiotics reduce serum uric acid levels via gut microbiota modulation: a randomized, controlled crossover trial in peritoneal dialysis patients. Eur J Nutr. 2021; 61(2):665-677. DOI: 10.1007/s00394-021-02669-y. View

Zhang M, Zhu X, Wu J, Huang Z, Zhao Z, Zhang X . Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015-16 and 2018-19. Front Immunol. 2022; 12:791983. PMC: 8858821. DOI: 10.3389/fimmu.2021.791983. View

Copur S, Demiray A, Kanbay M . Uric acid in metabolic syndrome: Does uric acid have a definitive role?. Eur J Intern Med. 2022; 103:4-12. DOI: 10.1016/j.ejim.2022.04.022. View

Liu X, Lv Q, Ren H, Gao L, Zhao P, Yang X . The altered gut microbiota of high-purine-induced hyperuricemia rats and its correlation with hyperuricemia. PeerJ. 2020; 8:e8664. PMC: 7061907. DOI: 10.7717/peerj.8664. View

10.

Wang R, Halimulati M, Huang X, Ma Y, Li L, Zhang Z . Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia. J Adv Res. 2022; 52:19-28. PMC: 10555773. DOI: 10.1016/j.jare.2022.11.003. View

11.

Ramos M, de Barros A, Razvickas C, Borges F, Schor N . Xanthine oxidase inhibitors and sepsis. Int J Immunopathol Pharmacol. 2018; 32:2058738418772210. PMC: 5967155. DOI: 10.1177/2058738418772210. View

12.

Kim H, Song H, Park S, Jang S, Park K, Song K . Terminalia chebula Retz. extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1/3 and NF-ĸB signaling in vitro. Phytomedicine. 2022; 104:154318. DOI: 10.1016/j.phymed.2022.154318. View

13.

Guo Y, Li H, Liu Z, Li C, Chen Y, Jiang C . Impaired intestinal barrier function in a mouse model of hyperuricemia. Mol Med Rep. 2019; 20(4):3292-3300. PMC: 6755192. DOI: 10.3892/mmr.2019.10586. View

14.

Ekambaram S, Babu K, Perumal S, Rajendran D . Repeated oral dose toxicity study on hydrolysable tannin rich fraction isolated from fruit pericarps of Terminalia chebula Retz in Wistar albino rats. Regul Toxicol Pharmacol. 2017; 92:182-188. DOI: 10.1016/j.yrtph.2017.12.001. View

15.

Wang X, Zhang X, Li J, Hu B, Zhang J, Zhang W . Analysis of prescription medication rules of traditional Chinese medicine for bradyarrhythmia treatment based on data mining. Medicine (Baltimore). 2022; 101(44):e31436. PMC: 9646641. DOI: 10.1097/MD.0000000000031436. View

16.

Bai L, Wu C, Lei S, Zou M, Wang S, Zhang Z . Potential anti-gout properties of Wuwei Shexiang pills based on network pharmacology and pharmacological verification. J Ethnopharmacol. 2023; 305:116147. DOI: 10.1016/j.jep.2023.116147. View

17.

Chen H, Zhang C, Yao Y, Li J, Du W, Li M . Study on anti-hyperuricemia effects and active ingredients of traditional Tibetan medicine TongFengTangSan (TFTS) by ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal. 2018; 165:213-223. DOI: 10.1016/j.jpba.2018.11.038. View

18.

Chen-Xu M, Yokose C, Rai S, Pillinger M, Choi H . Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007-2016. Arthritis Rheumatol. 2019; 71(6):991-999. PMC: 6536335. DOI: 10.1002/art.40807. View

19.

Hao Y, Ji Z, Shen Z, Xue Y, Zhang B, Yu D . Increase Dietary Fiber Intake Ameliorates Cecal Morphology and Drives Cecal Species-Specific of Short-Chain Fatty Acids in White Pekin Ducks. Front Microbiol. 2022; 13:853797. PMC: 9021919. DOI: 10.3389/fmicb.2022.853797. View

20.

Tao H, Zhong J, Mo Y, Liu W, Wang H . Exploring the Mechanism through which L. Extract Exerts Protective Effects against Acute Gouty Arthritis: A Network Pharmacology Study and Experimental Validation. Evid Based Complement Alternat Med. 2022; 2022:9748338. PMC: 9017503. DOI: 10.1155/2022/9748338. View